Is Intravenous Ketamine Better Than Intranasal Esketamine for Treating Treatment-Resistant Depression?
Zeeshan Mansuri1,2, Bhumika Shah3, Garima Yadav4
1Department of Psychiatry, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts.
The Primary Care Companion for CNS Disorders
|February 21, 2024
Abstract
No abstract available in PubMed .
Related Concept Videos
Electroconvulsive Therapy
39
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
39
Parenteral Anesthetics: Overview
125
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
125


